Aerie Pharmaceuticals, Inc. (AERI): Price and Financial Metrics

AERI POWR Grades

• Value is the dimension where AERI ranks best; there it ranks ahead of 90.15% of US stocks.
• AERI's strongest trending metric is Momentum; it's been moving up over the last 179 days.
• AERI's current lowest rank is in the Stability metric (where it is better than 2.94% of US stocks).

AERI Stock Summary

• The capital turnover (annual revenue relative to shareholder's equity) for AERI is -1.47 -- better than merely 4.35% of US stocks.
• Equity multiplier, or assets relative to shareholders' equity, comes in at -4.38 for AERIE PHARMACEUTICALS INC; that's greater than it is for only 3% of US stocks.
• Revenue growth over the past 12 months for AERIE PHARMACEUTICALS INC comes in at 118.21%, a number that bests 92.51% of the US stocks we're tracking.
• If you're looking for stocks that are quantitatively similar to AERIE PHARMACEUTICALS INC, a group of peers worth examining would be EMKR, ACER, MRIN, WISA, and IPGP.
• Visit AERI's SEC page to see the company's official filings. To visit the company's web site, go to www.aeriepharma.com.

AERI Valuation Summary

• In comparison to the median Healthcare stock, AERI's price/sales ratio is 89.47% higher, now standing at 3.6.
• Over the past 108 months, AERI's price/sales ratio has gone NA NA.

Below are key valuation metrics over time for AERI.

AERI Growth Metrics

Its 2 year net income to common stockholders growth rate is now at 65.76%.
• Its 2 year net cashflow from operations growth rate is now at 94.99%.
• The 3 year net cashflow from operations growth rate now stands at 95.52%.

AERI's revenue has moved up $207,125,000 over the prior 52 months.

The table below shows AERI's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-06-30	207.125	-0.282	-49.42
2022-03-31	200.999	-7.189	-68.737
2021-12-31	194.134	-99.154	-74.81
2021-09-30	104.151	-46.682	-166.48
2021-06-30	94.919	-50.191	-166.437
2021-03-31	85.767	-52.922	-175.936

AERI's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• AERI has a Quality Grade of C, ranking ahead of 68.87% of graded US stocks.
• AERI's asset turnover comes in at 0.255 -- ranking 175th of 682 Pharmaceutical Products stocks.
• UTHR, AMGN, and AMRN are the stocks whose asset turnover ratios are most correlated with AERI.

The table below shows AERI's key quality metrics over time.